Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early melatonin supplementation partially delays gastrointestinal aging.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Elevated TREM2 Expression in Tumor-associated Macrophages Suppresses Cytotoxic T Cell Infiltration and Facilitates Immune Escape in Colorectal Cancer.

Cellular and molecular gastroenterology and hepatology·2026
Same author

A(C)VPpred: Transfer Learning-Enhanced Prediction of Antiviral and Anticoronavirus Peptides from Sequence Data.

Journal of chemical information and modeling·2026
Same author

Design of permeability-optimized target-binding macrocycles <i>via</i> direct preference optimization.

Chemical science·2026
Same author

Bridging Generative AI and Diffusion Models With Molecular Simulation to Design Anti-Quorum-Sensing De novo Peptides Targeting LasR of Pseudomonas aeruginosa.

Probiotics and antimicrobial proteins·2026
Same author

Prosta-omics: machine learning-driven TPSA prediction and molecular modeling of ASPM-inhibitors for prostate cancer treatment.

Molecular diversity·2026

Related Experiment Video

Updated: Nov 3, 2025

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
04:17

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

Published on: May 10, 2024

1.1K

LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network.

Deshan Zhou, Shaoliang Peng, Dong-Qing Wei

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |June 3, 2021
    PubMed
    Summary

    A new AI model, LUNAR, identifies potential COVID-19 treatments by analyzing drug-target relationships. This approach accelerates drug discovery for the novel coronavirus (SARS-CoV-2) pandemic, offering promising candidates for further research and development.

    More Related Videos

    High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
    06:39

    High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells

    Published on: April 21, 2022

    3.3K
    Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
    10:25

    Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

    Published on: June 5, 2021

    4.9K

    Related Experiment Videos

    Last Updated: Nov 3, 2025

    DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
    04:17

    DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

    Published on: May 10, 2024

    1.1K
    High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
    06:39

    High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells

    Published on: April 21, 2022

    3.3K
    Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
    10:25

    Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

    Published on: June 5, 2021

    4.9K

    Area of Science:

    • Computational biology
    • Artificial intelligence in drug discovery
    • Network pharmacology

    Background:

    • The COVID-19 pandemic, caused by SARS-CoV-2, lacks specific antiviral drugs, necessitating urgent development of new therapeutic agents.
    • Existing drug discovery methods are time-consuming and costly, highlighting the need for innovative computational approaches.

    Purpose of the Study:

    • To develop and validate a novel deep learning model, LUNAR, for predicting potential drug candidates against COVID-19.
    • To leverage graph convolutional neural networks and attention mechanisms for enhanced drug-target interaction prediction.

    Main Methods:

    • LUNAR, a nonlinear end-to-end model, utilizes graph convolutional neural networks to learn from complex heterogeneous relational networks.
    • An attention mechanism is integrated to weigh the importance of different neighborhood information types for node representation.
    • Topology reconstruction is employed to extract feature representations of drugs and targets, facilitating relationship strength prediction.

    Main Results:

    • LUNAR achieved superior predictive performance with an Area Under the Curve (AUC) of 0.949 and an Area Under the Precision-Recall Curve (AUPR) of 0.866 via 10-fold cross-validation.
    • The model successfully identified candidate drugs for COVID-19 treatment, with some already appearing in clinical studies.
    • LUNAR demonstrated effective integration of topological information and improved model interpretability.

    Conclusions:

    • LUNAR is a powerful tool for accelerating drug discovery by accurately predicting drug candidates for COVID-19.
    • The model's ability to integrate network topology and attention mechanisms enhances its predictive accuracy and interpretability.
    • The identified drug candidates provide valuable references for experimental scientists, potentially speeding up the development of effective COVID-19 therapies.